Featured

Empagliflozin Slowed Kidney Disease Progression, Decreased Renal Events vs Placebo

Empagliflozin Slowed Kidney Disease Progression, Decreased Renal Events vs Placebo

Empagliflozin caused slower progression of kidney disease and reduced the rates of renal events compared with placebo when added to standard care.

Latest Coverage

Novel Program May Help Prevent DKA Hospitalizations in Youth with Type 1 Diabetes

Novel Program May Help Prevent DKA Hospitalizations in Youth with Type 1 Diabetes

A program focused on behavior reduced costs and improved glycemic control in children with repeat hospitalizations for diabetic ketoacidosis.

Ipragliflozin Performed Well in Insulin-Treated Japanese Patients With Type 2 Diabetes

Ipragliflozin Performed Well in Insulin-Treated Japanese Patients With Type 2 Diabetes

The SGLT2 inhibitor ipragliflozin was effective and well tolerated in Japanese patients with type 2 diabetes on insulin.

High Deductible Health Plan May Not Be Beneficial In High Morbidity Diabetes Patients

High Deductible Health Plan May Not Be Beneficial In High Morbidity Diabetes Patients

Researchers observed significant increases in costs per complication in patients with diabetes who are HDHP members.

Cardiovascular Disease Mortality Decreased Among Elderly Patients with Diabetes

Cardiovascular Disease Mortality Decreased Among Elderly Patients with Diabetes

Mortality rates have dropped significantly in diabetes patients over the age of 65 but not among those between 55 and 64 years of age.

Automated Home Monitor Effective for the Early Detection of Diabetic Foot Ulcer

Automated Home Monitor Effective for the Early Detection of Diabetic Foot Ulcer

An automated home monitor may reduce diabetic foot ulcer-related morbidity, mortality, and resource utilization.

T Cell Mitochondrial Dysfunction Linked to Human Type 1 Diabetes

T Cell Mitochondrial Dysfunction Linked to Human Type 1 Diabetes

T cell mitochondrial dysfunction in patients with type 1 diabetes may lead to abnormal T cell regulation.

Automated Artificial Pancreas System May Benefit Hospitalized Type 2 Diabetes Patients

Automated Artificial Pancreas System May Benefit Hospitalized Type 2 Diabetes Patients

The system was feasible, safe, and effective for managing hyperglycemia in this patient population.

Cumulative Life Stress Linked to Islet Autoimmunity in At-Risk Children

Cumulative Life Stress Linked to Islet Autoimmunity in At-Risk Children

Cumulative life stress was a risk factor for developing islet autoimmunity in children with high type 1 diabetes risk.

Faster Aspart Regimen Superior to Basal Insulin for Glycemic Control

Faster Aspart Regimen Superior to Basal Insulin for Glycemic Control

Faster aspart as part of a basal-bolus regimen improved glycemic control when compared with basal insulin only.

LEADER: Liraglutide Decreased Rate of CV Events in High-Risk Type 2 Diabetes

LEADER: Liraglutide Decreased Rate of CV Events in High-Risk Type 2 Diabetes

Compared with placebo, liraglutide decreased the rate of cardiovascular events in high-risk patients with diabetes.

Upcoming Meetings

Sign Up for Free e-Newsletters